Alfred Zippelius

32PUBLICATIONS

234CO-AUTHORS

Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)HaematologyRespiratory diseases

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (32)

Sort by Publication Date:

|Jul 14, 2026

Anti-PD1-IL18 immunoconjugate promotes effector T cell-mediated antitumor immunity.

|Jun 05, 2026

Cytotoxic CD39<sup>+</sup> tumor-associated NK cells respond to NKG2A blockade in lung cancer.

|May 29, 2026

Addition of Intravesical Recombinant Bacillus Calmette-Guérin to Perioperative Chemoimmunotherapy in Muscle-Invasive Bladder Cancer: Primary Analysis of the Single-Arm Phase II Trial SAKK 06/19.

|May 07, 2026

Author Correction: Proteasome-guided haem signalling axis contributes to T cell exhaustion.

|Mar 19, 2026

Proteasome-guided haem signalling axis contributes to T cell exhaustion.

Yingxi Xu, Yangtao Shangguan, Yu-Ming Chuang

|Feb 09, 2026

Cell Therapies and Bispecific Engagers: Redefining Strategies against Checkpoint Resistance.

Heinz Läubli, David König, Marco Donia

Pageof 6

Frequent Collaborators

12 joint publications

Heinz Laubli

10 joint publications

Marcel Trefny

Priska Auf der Maur

Marina Natoli

Nicole Kirchhammer

Daniela S Thommen

Kirsten Mertz

Clara Serger

Ping-Chih Ho

Mélanie Buchi

Frequent Collaborators

12 joint publications

Heinz Laubli

10 joint publications

Marcel Trefny

5 joint publications

Priska Auf der Maur

5 joint publications

Marina Natoli